GSK plc (NYSE:GSK)
| 35.88 Delayed Data As of 4:00pm ET |  -0.21 / -0.58%Today’s Change | 29.76 Today|||52-Week Range 39.74 | +2.11% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | 12.8B | 1.4B | 2.8B | 5.4B | |
| Depreciation | 2.5B | 2.4B | 2.5B | 2.5B | ||
| Total Other Cash Flow | -14.9B | 1.8B | 1.7B | 57.3M | ||
| Funds From Operations | 360.0M | 5.6B | 6.6B | 7.4B | ||
| Funds From/For Other Operating Expenses | -2.6B | -2.3B | -1.4B | -3.0B | ||
| Net Cash Flow - Operating Activities | 2.9B | 7.9B | 8.0B | 10.4B | ||
| Investing | Increase In Investments | -152.5M | -144.0M | -122.3M | -425.4M | |
| Decrease In Investments | 1.4B | 919.1M | 340.0M | 205.3M | ||
| Capital Expenditures | -2.1B | -2.1B | -2.0B | -1.8B | ||
| Fixed Asset Disposal | 15.7B | 251.7M | 752.1M | 286.7M | ||
| Net Assets From Acquisitions | -5.4B | 0.00 | -154.5M | -12.6B | ||
| Other Investing - Uses | 0.00 | -98.2M | 0.00 | 0.00 | ||
| Other Investing - Sources | 360.0M | 380.8M | 61.8M | 341.4M | ||
| Net Cash Flow Investing | 9.0B | -1.9B | -2.0B | -14.6B | ||
| Financing | Short Term Borrowings | -3.6B | 129.2M | -4.1B | -2.6B | |
| Long Term Borrowings | 0.00 | 0.00 | 2.9B | 13.5B | ||
| Long Term Debt Reduction | -38.1M | -24.2M | -29.6M | -37.3M | ||
| Net Proceeds Stock Sale | 111.3M | 119.8M | 72.1M | 98.7M | ||
| Common Preferred Redeemed | -151.0M | -99.6M | -83.7M | 0.00 | ||
| Common Dividends | -5.9B | -6.5B | -5.0B | -5.2B | ||
| Cash Dividends Paid - Total | -5.9B | -6.5B | -5.0B | -5.2B | ||
| Other Sources - Financing | 355.4M | 0.00 | 119.8M | -- | ||
| Other Uses - Financing | 361.5M | 1.3B | 1.0B | 793.4M | ||
| Net Cash Flow - Financing | -9.6B | -7.7B | -7.2B | 4.9B | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -68.6M | 380.8M | -128.8M | 10.7M | |
| Net Change In Cash | 2.3B | -1.6B | -1.2B | 638.7M | ||
